Detalles de la búsqueda
1.
Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.
Neurourol Urodyn
; 37(3): 986-996, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29140559
2.
Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom.
Value Health
; 18(6): 783-90, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26409605
3.
Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
Health Qual Life Outcomes
; 11: 200, 2013 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246044
4.
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK.
J Mark Access Health Policy
; 6(1): 1438721, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29686801
5.
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis.
Eur Urol
; 74(3): 324-333, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29699858
6.
Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings.
J Mark Access Health Policy
; 42016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27857827
7.
The value of childhood combination vaccines: From beliefs to evidence.
Hum Vaccin Immunother
; 11(9): 2132-41, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26075806
8.
Cost effectiveness of mirabegron compared with tolterodine extended release for the treatment of adults with overactive bladder in the United Kingdom.
Clin Drug Investig
; 35(2): 83-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25491433
9.
Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison.
Eur Urol
; 65(4): 755-65, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24275310
10.
Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.
Expert Opin Pharmacother
; 13(1): 9-16, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22107732
11.
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands.
Neuropsychiatr Dis Treat
; 7: 313-7, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21822384
12.
The 6-month persistence on SSRIs and associated economic burden.
J Med Econ
; 13(3): 527-36, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20701432
13.
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
J Med Econ
; 13(3): 516-26, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20698748
14.
Anxiety disorders, major depressive disorder and the dynamic relationship between these conditions: treatment patterns and cost analysis.
J Med Econ
; 13(1): 99-109, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20078336
Resultados
1 -
14
de 14
1
Próxima >
>>